Antivirals

Antivirals

Biodefense Headlines – 31 March 2025

Biosecurity March 31, 2025

This week’s topics include restructuring of ASPR, anti-vaccine leadership at NIH, the UK’s new pathogen priority research targets list, and data on a post-exposure treatment for filoviruses. FEATURED Trump Administration…

US Ambassador Visits Malaria Research Sites in Cambodia

DoD Seeks Countermeasures Against Filoviridae Viruses

DoD-Backed Influenza Drug Starts Phase 3 Studies

Novel Technique for Finding Malaria Drug Targets

Evaluation of Countermeasures Against Arenaviruses

Mining the Immune Systems of Ebola Survivors

New Look at Tamiflu Shows Reduced Complications, Faster Recovery

Low Flu Vaccination Rates Among Nursing Home Employees

Genetic Changes in Ebola Could Impede Countermeasures

DynPort Awarded up to 90M for Phase 1 Clinical Trials

PharmAthene Awarded $195M+ in SIGA Smallpox Lawsuit

NIH Expands Early-Stage Human Testing of Countermeasures

Brain Discovery Could Lead to New Treatments for the Flu

UC Davis Working to Help Speed Ebola Drug Production

New Findings May Help Combat Enterovirus D68

Hemopurifier Ebola Treatment Protocol Approved

Tekmira to Provide TKM-Ebola-Guinea for Clinical Studies in W. Africa

53 Approved Drugs May Help Block Ebola Infection

Teaming Up with the U.S. Army to Treat Hantavirus

Military Seeks Support for Arenaviruses Countermeasures

Biodefense Headlines – 31 March 2025